ZA973664B - Hepatitis b monoclonal antibodies - Google Patents

Hepatitis b monoclonal antibodies

Info

Publication number
ZA973664B
ZA973664B ZA973664A ZA973664A ZA973664B ZA 973664 B ZA973664 B ZA 973664B ZA 973664 A ZA973664 A ZA 973664A ZA 973664 A ZA973664 A ZA 973664A ZA 973664 B ZA973664 B ZA 973664B
Authority
ZA
South Africa
Prior art keywords
hepatitis
monoclonal antibodies
monoclonal
antibodies
Prior art date
Application number
ZA973664A
Other languages
English (en)
Inventor
Richard Seaton Tedder
Samreenljaz
Ruth Bridget Ferns
Original Assignee
Murex Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Murex Diagnostics Corp filed Critical Murex Diagnostics Corp
Publication of ZA973664B publication Critical patent/ZA973664B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA973664A 1996-04-25 1997-04-25 Hepatitis b monoclonal antibodies ZA973664B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9608626.9A GB9608626D0 (en) 1996-04-25 1996-04-25 Hepatitis b monoclonal antibodies

Publications (1)

Publication Number Publication Date
ZA973664B true ZA973664B (en) 1998-08-20

Family

ID=10792667

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973664A ZA973664B (en) 1996-04-25 1997-04-25 Hepatitis b monoclonal antibodies

Country Status (10)

Country Link
US (1) US7393933B1 (de)
EP (1) EP0904378B1 (de)
JP (1) JP4118955B2 (de)
AU (1) AU2645297A (de)
CA (1) CA2252466C (de)
DE (1) DE69738312T2 (de)
ES (1) ES2297855T3 (de)
GB (1) GB9608626D0 (de)
WO (1) WO1997040164A1 (de)
ZA (1) ZA973664B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
JP2001508054A (ja) * 1996-12-30 2001-06-19 イノジェネティックス・ナムローゼ・フェンノートシャップ ＨＢｓＡｇ由来アネキシンＶ結合ポリペプチドおよびその使用
EP1111388A1 (de) * 1999-12-23 2001-06-27 Universiteit Gent Interaktion zwischen CD14 und HBV-Komponenten
US7067247B2 (en) * 2000-03-31 2006-06-27 Ortho-Clinical Diagnostics, Inc. Hepatitis B virus surface protein
FR2815634B1 (fr) * 2000-10-20 2003-10-31 Biomerieux Sa Anticorps monoclonaux diriges contre des virus de l'hepatite b
DE10339927A1 (de) * 2003-08-29 2005-03-24 Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen
CA2569561C (en) * 2004-06-07 2014-08-12 Chiron Corporation Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
JP4948783B2 (ja) * 2005-05-18 2012-06-06 シスメックス株式会社 抗ＨＢｓモノクローナル抗体
CA2667859C (en) * 2006-10-30 2017-01-24 Advanced Life Science Institute, Inc. Method for analysis of hepatitis b virus s antigen
EP3274051A4 (de) * 2015-03-25 2018-08-22 IGM Biosciences A/S Multivalente hepatitis-b-virus-antigenbindemoleküle und verwendungen davon
WO2017059878A1 (en) * 2015-10-07 2017-04-13 Humabs Biomed Sa Antibodies that potently neutralize hepatitis b virus and uses thereof
CN113480641B (zh) * 2017-04-07 2023-04-11 厦门大学 用于治疗乙肝感染及相关疾病的抗体
KR102084912B1 (ko) * 2019-01-17 2020-03-05 주식회사 녹십자 B형 간염 바이러스 표면 항원의 입체 에피토프 및 이에 특이적으로 결합하는 항체
CN111659355B (zh) * 2020-06-23 2022-12-13 武汉瑞法医疗器械有限公司 烷基化修饰的乙肝病毒免疫吸附剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2158866A1 (en) * 1993-03-24 1994-09-29 Jennifer Anne Waters Hepatitis b escape mutant specific binding molecules
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid

Also Published As

Publication number Publication date
CA2252466C (en) 2010-04-06
EP0904378B1 (de) 2007-11-21
WO1997040164A1 (en) 1997-10-30
CA2252466A1 (en) 1997-10-30
JP4118955B2 (ja) 2008-07-16
GB9608626D0 (en) 1996-07-03
US7393933B1 (en) 2008-07-01
EP0904378A1 (de) 1999-03-31
JP2000509269A (ja) 2000-07-25
AU2645297A (en) 1997-11-12
DE69738312D1 (de) 2008-01-03
ES2297855T3 (es) 2008-05-01
DE69738312T2 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
IL128406A0 (en) Monoclonal antibodies
PL311926A1 (en) Anti-alphav-integrinic monoclonal antibodies
GB9603256D0 (en) Antibodies
ZA959336B (en) Antibodies
ZA979185B (en) Anti-ErbB2 antibodies
EP1073464A4 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
IL130143A0 (en) Humanized anti-CD11a antibodies
GB9608626D0 (en) Hepatitis b monoclonal antibodies
GB9412166D0 (en) Retargetting antibodies
HUP9800744A3 (en) Antibodies against fas-antigene
EP0977590A4 (de) Menschliche monoklonale antikörper
EP0909278A4 (de) Mit einer nephropathie zusammenhängendes immunglobulin g und antikörper dagegen
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
GB9718911D0 (en) Monoclonal antibodies
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
GB9615027D0 (en) Monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
AP9801381A0 (en) Anti-human mp52 monoclonal antibody
GB9415331D0 (en) Antibodies
GB9406222D0 (en) Huminised antibodies
IL134049A0 (en) Anti-cryptdin antibodies
GB9406243D0 (en) Antibodies
GB9406244D0 (en) Altered antibodies
GB9401597D0 (en) Altered antibodies